Multimedia

In this video, Psych Congress Steering Committee member Vladimir Maletic, MD, MS, discusses the concept of complex attention/deficit-hyperactivity disorder, how it is defined, and how to respond to it.

Psych Congress Steering Committee member Vladimir Maletic, MD, MS, summarizes some recent findings related to genome‑wide association studies examining attention/deficit-hyperactivity disorder (ADHD).

With the approval of psychedelic medicines imminent, the Psychiatry & Behavioral Health Learning Network (PBHLN) has announced that its inaugural Sana Symposium will take place Sept. 17-19, 2021.

Ronan Levy, co-founder and executive chairman of Field Trip Health, joins the BHE Podcast to discuss transitioning from practicing law to entrepreneurship endeavors that challenge the status quo, surging interest in the therapeutic potential of psychedelics, the future of psychedelics in the United States, how Field Trip is expanding its operations across multiple countries, and the organization’…

Jonathan E. Alpert, MD, PhD, of Albert Einstein College of Medicine and Montefiore Medical Center, New York City, New York, discusses the occurrence of medical comorbidities in patients with depression.

Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses an article he cowrote on nonstimulant treatment options for pediatric attention-deficit/hyperactivity disorder (ADHD).

In this video, Psych Congress Steering Committee member Vladimir Maletic, MD, MS, discusses the noncore symptoms of attention/deficit-hyperactivity disorder (ADHD) and how they are relevant to diagnosis and treatment.

Psych Congress Steering Committee member Charles Raison, MD, discusses heat, including sauna use, as a novel treatment for depression and a tool for improving mental health.

Using a genetics-based statistical approach, researchers from the United Kingdom found attention-deficit/hyperactivity disorder (ADHD) to have a causal effect on childhood obesity and coronary artery disease.

In this podcast, Roger McIntyre, MD, FRCPC, discusses his seminar that was written as a "state of the union" address regarding the current state of bipolar disorder (BD) treatment and where it is going in the future.